Updates

McBride

February 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Ahead of results on 24 February, McBride said that through significant downsizing of its portfolio to eliminate marginal products and by focusing on larger customers as per the new “Repair, Prepare, Grow” strategy, it has been continuing to bolster margins and H1 profits will be ahead of last year. That is at a time when top line growth has been harder to come by (H1 sales are +0.4% at constant currency).Pretax profit forecast for the year to end June is expected to climb from £21.7m to £27m (eps 10.5p), with next year seeing further improvement to £31.9m (eps 12.5p). Await results. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Staffline - Eps forecast lifted from 107.6p to 117p

Fusionex - FY16 to be an investment year

McBride - Private label volumes up and contract manufacturing recovers (September 2024)

McBride -Net debt now <1.6x vs 2x expectation (June 2024)

McBride - Barnstorming H1 and a 20% eps upgrade (April 2024)

McBride - Trading at top end of range (February 2024)

McBride - Massive eps upgrade from 5.5p to 15.1p (December 2023)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X